SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : OmniCorder Technologies, Inc. (OMCT)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: RikRichter who wrote (19)3/21/2004 6:20:42 AM
From: Mahatmabenfoo   of 63
 
Rik provided this information:
> PMOS applies to AMEX for listing of its shares:
> freeedgar.com

Yep. It "applied", which by itself means very little.

The SEC statement you quote also says this:

"We have conducted clinical testing of our BioScanIR technology in our initial target market segments with the successful publication of the results"

very devious wording. The TESTS were not necessarily successful -- they were just successfully "published"!

It also says this:

"Our pilot program involves the installation of our
systems for evaluation by physicians, technicians and patients. Our pilot program has already produced what we believe to be positive results based on the feedback we have received, and we anticipate converting the pilot program installations into revenue-generating units in the near future."

So they have the machines for free, they know what they can do, and still have paid ZERO -- not even some token payment so PMOS can claim a real sale.

The longer there is no sale, the more what this company has appears to have no value. Time will tell, or maybe, already HAS told -- months now after its reverse merger, NO sales.

A clue.

- Charles
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext